Etoposide EP Impurity A, with the CAS number 124151-67-3, is a chemical compound that is recognized as an impurity associated with the anticancer drug etoposide. This substance is typically characterized by its molecular structure, which includes specific functional groups that may influence its chemical behavior and biological activity. Etoposide itself is a topoisomerase inhibitor used primarily in cancer treatment, and impurities like Etoposide EP Impurity A can arise during the synthesis or formulation processes. The presence of such impurities is significant in pharmaceutical development, as they can affect the efficacy, safety, and regulatory compliance of the final drug product. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify impurities like Etoposide EP Impurity A in pharmaceutical formulations. Understanding the characteristics of this impurity is crucial for ensuring the quality and safety of etoposide-containing medications.

Etoposide EP Impurity A

124151-67-3: Etoposide EP Impurity A, with the CAS number 124151-67-3, is a chemical compound that is recognized as an impurity associated with the anticancer drug etoposide. This substance is typically characterized by its molecular structure, which includes specific functional groups that may influence its chemical behavior and biological activity. Etoposide itself is a topoisomerase inhibitor used primarily in cancer treatment, and impurities like Etoposide EP Impurity A can arise during the synthesis or formulation processes. The presence of such impurities is significant in pharmaceutical development, as they can affect the efficacy, safety, and regulatory compliance of the final drug product. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify impurities like Etoposide EP Impurity A in pharmaceutical formulations. Understanding the characteristics of this impurity is crucial for ensuring the quality and safety of etoposide-containing medications.

CAS 124151-67-3

Etoposide EP Impurity A

Etoposide EP Impurity A

Ref: 4Z-E-5912

Etoposide EP Impurity A

Ref: ST-EA-CP-E31001